REQUEST A DEMO
Total
USD $0.00
Search more companies

Novo Nordisk Pharma Operations AS (Ecuador)

Main Activities: Pharmaceutical and Medicine Manufacturing
Secondary Activities: Medicinal and Botanical Manufacturing
Full name: Novo Nordisk Pharma Operations AS Profile Updated: May 14, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

Novo Nordisk Pharma Operations AS is an enterprise in Ecuador, with the main office in Quito. It operates in the Pharmaceutical and Medicine Manufacturing industry. It was established on April 02, 2018. 2 (2023) employees currently work for Novo Nordisk Pharma Operations AS. The latest financial highlights indicate a net sales revenue increase of 15.26% in 2023. Over the same period, its total assets grew by 52.43%. In 2023, Novo Nordisk Pharma Operations AS’s net profit margin decreased by 0.38%.

Headquarters
Luxemburgo N34-359, Cosmopolitan Parc Bldg.
Quito; Pichincha;

Contact Details: Purchase the Novo Nordisk Pharma Operations AS report to view the information.

Basic Information
Total Employees:
Purchase the Novo Nordisk Pharma Operations AS report to view the information.
Outstanding Shares:
Purchase the Novo Nordisk Pharma Operations AS report to view the information.
Registered Capital:
Purchase the Novo Nordisk Pharma Operations AS report to view the information.
Incorporation Date:
April 02, 2018
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Novo Nordisk Pharma Operations AS report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
15.26%
Total operating revenue
15.26%
Operating profit (EBIT)
15.02%
EBITDA
124.63%
Net Profit (Loss) for the Period
-4.52%
Total assets
52.43%
Total equity
13.46%
Operating Profit Margin (ROS)
-0.01%
Net Profit Margin
-0.38%
Return on Equity (ROE)
-2.36%
Debt to Equity Ratio
14.75%
Quick Ratio
-0.41%
Cash Ratio
-0.07%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?